According to data from qichacha quoted by Securities Times, Shanghai Runan Linghang Pharmaceutical Development Co., Ltd. was established by Sino Biopharm's wholly-owned indirect holding, with Li He as the legal representative and registered capital of 11 million RMB. The company mainly engages in software development, goods import and export, import and export agency, personal business services, tax services, government procurement agency services, and offshore trade operations.
中國生物製藥(01177.HK)上海成立醫藥發展公司
Sino Biopharm (01177.HK) established a pharmaceutical development company in Shanghai.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.